Although recent evidence suggests that Myc-amplified cancer cells are sensitive to the CLK inhibitor T-025 [20], little is known about whether CLK inhibitors are involved in the expression and splicing modulation of apoptosis-related genes to inhibit cell growth and induce apoptosis. The gene discussed is CLK1; the disease is cancer.